AI assistant
Sending…
Capstone Holding Corp. — Director's Dealing 2015
Apr 14, 2015
35323_dirs_2015-04-13_df23b6f1-74f5-4a1d-a58b-6ae6a95e97f9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2015-04-10
Reporting Person: Fangmann Eric W (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-04-10 | Stock Options (Right to Buy) | $0.17 | A | 10000 | Acquired | 2025-04-10 | Common Stock (10000) | Direct |
More from Capstone Holding Corp.
Regulatory Filings
2026
Jul 9
Regulatory Filings
2026
Jul 6
Capital/Financing Update
2026
Jun 26
Capital/Financing Update
2026
Jun 26
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 22
Capital/Financing Update
2026
Jun 12
Interim / Quarterly Report
2026
May 20
Proxy Solicitation & Information Statement
2026
May 8
Annual Report
2026
May 7
Proxy Solicitation & Information Statement
2026
May 7